[{"NetIncomeLoss_1_Q3_USD":-58684000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":14782000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":130447000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":312000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":15227000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":4953000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":-7000.0,"PaymentsToAcquireInvestments_3_Q3_USD":92337000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":12988000.0,"AssetsCurrent_0_Q3_USD":496777000.0,"ContractWithCustomerAssetNetNoncurrent_0_Q3_USD":13357000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":26100000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":26100000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1413000.0,"AccruedSalariesCurrent_0_Q3_USD":6843000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":12610000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":290000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-311000.0,"CommonStockSharesIssued_0_Q3_shares":87004686.0,"Assets_0_Q3_USD":626443000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":67130000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":188784000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":86887280.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":80715564.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8351000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":23583000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":59937000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1079000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":86641000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":30694000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":194022000.0,"OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_0_Q3_USD":0.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":15200000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-25590000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-27197000.0,"AccountsReceivableNetCurrent_0_Q3_USD":3243000.0,"CommonStockValue_0_Q3_USD":87000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-2626000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":87171000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":13779000.0,"ProceedsFromIssuanceOfPrivatePlacement_3_Q3_USD":50000000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":277928000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q3_USD":0.0,"OtherAssetsNoncurrent_0_Q3_USD":9000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":349130000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":83156000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":99950000.0,"CapitalizedContractCostAmortization_3_Q3_USD":1260000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-311000.0,"OperatingLeaseLiability_0_Q3_USD":85486000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":2226000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":13378000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":12204000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"VariableLeaseCost_3_Q3_USD":1633000.0,"VariableLeaseCost_1_Q3_USD":608000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-503821000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":264316000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":3243000.0,"CommonStockSharesOutstanding_0_Q3_shares":87004686.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"RestrictedCashNoncurrent_0_Q3_USD":15227000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":7843000.0,"StraightLineRentAdjustments_3_Q3_USD":8948000.0,"StraightLineRentAdjustments_1_Q3_USD":3039000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-18565000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-821000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":9741000.0,"AccountsPayableCurrent_0_Q3_USD":3717000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4729000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":4770000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":3813000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.084,"ShortTermLeaseCost_3_Q3_USD":900000.0,"ShortTermLeaseCost_1_Q3_USD":200000.0,"AdditionalPaidInCapital_0_Q3_USD":927784000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":364357000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1183000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":20710000.0,"NetIncomeLoss_3_Q3_USD":-120276000.0,"LiabilitiesCurrent_0_Q3_USD":54195000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-58995000.0,"LongTermInvestments_0_Q3_USD":13233000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":49378000.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":15538000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":7558000.0,"OperatingIncomeLoss_3_Q3_USD":-94686000.0,"OperatingIncomeLoss_1_Q3_USD":-31487000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q3_USD":0.0,"InvestmentIncomeInterest_3_Q3_USD":2054000.0,"InvestmentIncomeInterest_1_Q3_USD":447000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":17121000.0,"PreferredStockValue_0_Q3_USD":3000.0,"OperatingLeaseCost_3_Q3_USD":10581000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2660000.0,"OperatingLeaseCost_1_Q3_USD":3647000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":21992000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":7843000.0,"SharePrice_0_Q3_USD":39.97,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2330000.0,"OperatingExpenses_3_Q3_USD":110224000.0,"OperatingExpenses_1_Q3_USD":39045000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":48099000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.49,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.68,"ProfitLoss_3_Q3_USD":-120276000.0,"StockholdersEquity_0_Q3_USD":424365000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":626443000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-119986000.0,"Ticker":"FATE","CIK":"1434316","name":"FATE THERAPEUTICS INC","OfficialName":"Fate Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3545646272.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]